Cardiology and circulatory sciences (including cardiovascular disease)

Loewen, Peter

Faculty of Pharmaceutical Sciences

Faculty (G+PS eligible/member)

Cardiology and circulatory sciences (including cardiovascular disease); Clinical pharmacy and pharmacy practice; Knowledge translation and implementation science in health; atrial fibrillation; Pharmacoepidemiology; Thrombosis and Embolism; adherence to medication; Cardiovascular diseases; Arrhythmia; Heart Failure; stroke; Health Care Technologies; Professional Practices; Hematology; decision making; clinical prediction rules; healthcare communication technologies; hospital pharmacy practice; knowledge translation of evidence to patient care; patient complexiometry; patient decision aids; patient education; pharmacy practice; prediction of stroke and bleeding in atrial fibrillation patients; quality of care, quality drug therapy; Shared decision-making; stroke prevention therapy; use of mobile technology for clinical decision-making

O'Neil, Michael

Faculty of Medicine

Faculty (non-G+PS member)

Cardiology and circulatory sciences (including cardiovascular disease); ketamine

Turgeon, Ricky

Faculty of Pharmaceutical Sciences

Faculty (G+PS eligible/member)

Cardiology and circulatory sciences (including cardiovascular disease); Health care effectiveness and outcomes; Knowledge translation and implementation science in health; Heart failure pharmacotherapy; Acute coronary syndromes / myocardial infarction; Cardiovascular risk reduction (lipid-lowering therapy, antiplatelet therapy); Cardiovascular safety of medications; Drug Effectiveness; Evidence-based practice; Shared decision making; Point-of-care decision aids / decision support tools; Knowledge translation / implementation; Risk calculators / clinical prediction tools; Pharmacist scope of practice

Wang, Ying

Department of Pathology & Laboratory Medicine, Faculty of Medicine

Faculty (G+PS eligible/member)

Cardiology and circulatory sciences (including cardiovascular disease); Cell differentiation, proliferation and death; Drug discovery, design and delivery; atherosclerosis; Diabetic cardiomyopathy; Vascular biology; Spatial 'Omics'; Drug repurposing and therapeutic design; Disease modeling; Digital Pathology

��